News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zeltia Group (18494051.MA) Says Yondelis on Track, Delays Neuropharma Unit IPO


3/6/2008 8:36:40 AM

MADRID, March 6 (Reuters) - Spanish pharmaceuticals firm Zeltia said on Thursday anti-cancer drug Yondelis was meeting forecasts but said the listing of its Neuropharma unit would be delayed because of poor markets.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES